[go: up one dir, main page]

FI880716A7 - Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar - Google Patents

Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar

Info

Publication number
FI880716A7
FI880716A7 FI880716A FI880716A FI880716A7 FI 880716 A7 FI880716 A7 FI 880716A7 FI 880716 A FI880716 A FI 880716A FI 880716 A FI880716 A FI 880716A FI 880716 A7 FI880716 A7 FI 880716A7
Authority
FI
Finland
Prior art keywords
arylpiperazinylalkylenephenyl
substituted heterocyclic
heterocyclic compounds
therapeutically useful
preparing therapeutically
Prior art date
Application number
FI880716A
Other languages
English (en)
Finnish (fi)
Other versions
FI880716A0 (sv
FI91752B (sv
FI91752C (sv
Inventor
Iii John Adams Lowe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI880716A0 publication Critical patent/FI880716A0/sv
Publication of FI880716A7 publication Critical patent/FI880716A7/sv
Publication of FI91752B publication Critical patent/FI91752B/sv
Application granted granted Critical
Publication of FI91752C publication Critical patent/FI91752C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI880716A 1987-02-17 1988-02-16 Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar FI91752C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8700340 1987-02-17
US8700340 1987-02-17

Publications (4)

Publication Number Publication Date
FI880716A0 FI880716A0 (sv) 1988-02-16
FI880716A7 true FI880716A7 (sv) 1988-08-18
FI91752B FI91752B (sv) 1994-04-29
FI91752C FI91752C (sv) 1994-08-10

Family

ID=22202287

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880716A FI91752C (sv) 1987-02-17 1988-02-16 Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar

Country Status (30)

Country Link
EP (1) EP0279598B1 (sv)
JP (1) JPH0699405B2 (sv)
KR (1) KR900004126B1 (sv)
CN (1) CN1015627B (sv)
AP (1) AP88A (sv)
AR (1) AR245125A1 (sv)
AT (1) ATE94537T1 (sv)
AU (1) AU583761B2 (sv)
CA (1) CA1312080C (sv)
CS (1) CS272783B2 (sv)
DD (1) DD272080A5 (sv)
DE (1) DE3884007T2 (sv)
DK (1) DK170878B1 (sv)
EG (1) EG18635A (sv)
ES (1) ES2058249T3 (sv)
FI (1) FI91752C (sv)
HU (1) HU207731B (sv)
IE (1) IE61258B1 (sv)
IL (1) IL85368A0 (sv)
IN (1) IN171858B (sv)
MA (1) MA21183A1 (sv)
MX (1) MX174210B (sv)
MY (1) MY103210A (sv)
NO (1) NO170582C (sv)
NZ (1) NZ223530A (sv)
PL (1) PL157118B1 (sv)
PT (1) PT86766B (sv)
SU (1) SU1634136A3 (sv)
YU (1) YU46624B (sv)
ZA (1) ZA881064B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
US5166156A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
US5166157A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
US5162324A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie Naphyl piperazines useful as 5-HT1A receptor ligands
JP3057763B2 (ja) * 1995-06-06 2000-07-04 ヘキスト・マリオン・ルセル・インコーポレイテツド 抗精神病薬としてのベンゾイソオキサゾール及びインダゾール誘導体
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
PL327582A1 (en) 1995-12-29 1998-12-21 Boehringer Ingelheim Pharma Derivatives of phenylthiazole exhibiting antiviral properties against herpes virues
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
WO1999001420A1 (en) * 1997-07-03 1999-01-14 Taito Co., Ltd. Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process
HK1215170A1 (zh) 2012-11-14 2016-08-19 The Johns Hopkins University 治療精神分裂症的方法和組合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2927924A (en) * 1958-04-03 1960-03-08 Lilly Co Eli Novel phenethyl-substituted piperazines
GB948766A (en) * 1959-10-20 1964-02-05 May & Baker Ltd Trifluoromethylphenylpiperazine derivatives
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
JPS5910675B2 (ja) * 1976-03-22 1984-03-10 ウェルファイド株式会社 アラルキルアミン誘導体
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物

Also Published As

Publication number Publication date
AU1174088A (en) 1988-08-18
PL157118B1 (pl) 1992-04-30
PT86766B (pt) 1992-05-29
NO880667D0 (no) 1988-02-16
IL85368A0 (en) 1988-07-31
CN88100986A (zh) 1988-09-21
ZA881064B (en) 1989-09-27
MX10428A (es) 1993-09-01
AP88A (en) 1990-06-06
DK78888D0 (da) 1988-02-16
AP8800082A0 (en) 1988-02-01
NZ223530A (en) 1990-07-26
CS272783B2 (en) 1991-02-12
FI880716A0 (sv) 1988-02-16
YU46624B (sh) 1994-01-20
KR900004126B1 (ko) 1990-06-16
IN171858B (sv) 1993-01-23
DE3884007D1 (de) 1993-10-21
ES2058249T3 (es) 1994-11-01
SU1634136A3 (ru) 1991-03-07
NO170582C (no) 1992-11-04
EG18635A (en) 1994-04-30
NO170582B (no) 1992-07-27
KR880009964A (ko) 1988-10-06
CN1015627B (zh) 1992-02-26
JPH0699405B2 (ja) 1994-12-07
HUT50334A (en) 1990-01-29
PT86766A (pt) 1988-03-01
MX174210B (es) 1994-04-28
YU30388A (en) 1989-10-31
JPS63216875A (ja) 1988-09-09
FI91752B (sv) 1994-04-29
EP0279598B1 (en) 1993-09-15
DD272080A5 (de) 1989-09-27
AU583761B2 (en) 1989-05-04
MA21183A1 (fr) 1988-10-01
CA1312080C (en) 1992-12-29
IE880420L (en) 1988-08-17
ATE94537T1 (de) 1993-10-15
DE3884007T2 (de) 1994-01-20
MY103210A (en) 1993-05-29
PL270653A1 (en) 1988-12-08
HU207731B (en) 1993-05-28
AR245125A1 (es) 1993-12-30
FI91752C (sv) 1994-08-10
EP0279598A2 (en) 1988-08-24
DK170878B1 (da) 1996-02-26
NO880667L (no) 1988-08-18
EP0279598A3 (en) 1989-07-26
DK78888A (da) 1988-08-18
IE61258B1 (en) 1994-10-19
CS96488A2 (en) 1990-04-11

Similar Documents

Publication Publication Date Title
FI883064A7 (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
FI893433A7 (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
FI880941A7 (sv) Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar
FI885917A7 (sv) Förfarande för framställning av heterocykliska föreningar
FI885409A7 (sv) Förfarande för framställning av nya terapeutiskt användbara pyridazinaminderivat
FI905941A7 (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat
FI883249A7 (sv) Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat
FI881180L (sv) Förfarande för framställning av terapeutiskt användbara tetrahydronaftalenderivat
FI883050L (sv) Förfarande för framställning av terapeutiskt aktiva pyranoindolizinokinolinderivat
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
FI854797A7 (sv) Förfarande för framställning av terapeutiskt användbara oxetanoner
FI872785A7 (sv) Förfarande för framställning av terapeutiskt användbara triazolföreningar
FI880816A7 (sv) Förfarande för framställning av nya terapeutiskt användbara kinoxalinderivat
BG49939A3 (bg) Метод за получаване на 2-анилино-пиримидинови производни
FI893405L (sv) Förfarande för framställning av kinolonföreningar
FI882030A7 (sv) Förfarande för framställning av terapeutiskt aktiva polycykliska heterocykliska föreningar
FI884627A7 (sv) Förfarande för framställning av nya terapeutiskt användbara dideoxicytidinderivat
FI880869A7 (sv) Förfarande för framställning av terapeutiskt aktiva tetrazolderivat
FI884553A7 (sv) Analogiförfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridinderivat
FI883889A7 (sv) Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat
FI883672A7 (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI880467A7 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
FI884910A7 (sv) Förfarande för framställning av terapeutiskt användbart bensopyranderivat
FI880716A7 (sv) Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar
FI881525A7 (sv) Förfarande för framställning av nya terapeutiskt användbara N-arylpiperazinacetamidderivat

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: PFIZER INC.